Zentek (ZTEK) Total Non-Current Liabilities (2021 - 2026)
Zentek (ZTEK) posted quarterly Total Non-Current Liabilities of $1.3 million for Q1 2026, up 1032.98% year-on-year from $112717.2 in Q1 2025, and up 4.05% on a QoQ basis from $1.2 million in Q4 2025.
Zentek (ZTEK) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
Zentek (ZTEK) has reported Total Non-Current Liabilities for 6 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 1032.98% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 1032.98% YoY) and the FY2026 annual result came in at $1.3 million, up 989.22% from the prior year.
- Total Non-Current Liabilities grew to $1.3 million in Q1 2026 per ZTEK's latest filing, from $1.2 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for ZTEK reached as high as $1.3 million in Q1 2026 and fell as low as $112717.2 in Q1 2025.
- A 5-year average of $609679.2 and a median of $500357.5 in 2023 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2025 — Total Non-Current Liabilities slumped 74.38% — and 2026, when it jumped 1032.98%.
- Year by year, Total Non-Current Liabilities stood at $186696.7 in 2022, then soared by 198.87% to $557978.9 in 2023, then tumbled by 73.45% to $148127.8 in 2024, then jumped by 728.56% to $1.2 million in 2025, then grew by 4.05% to $1.3 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.3 million, $1.2 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Zentek | 57.20 Mn | 56.25 Mn | -979,642.64 | 1.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 112,717.18 |
| Dec 31, 2024 | 148,127.80 |
| Sep 30, 2024 | 183,725.91 |
| Jun 30, 2024 | 309,562.71 |
| Mar 31, 2024 | 439,955.14 |
| Dec 31, 2023 | 557,978.90 |
| Sep 30, 2023 | 500,357.48 |
| Jun 30, 2023 | 621,526.99 |
| Mar 31, 2023 | 358,646.22 |
| Dec 31, 2022 | 186,696.73 |
| Sep 30, 2022 | 422,293.16 |
| Jun 30, 2022 | 661,430.55 |
| Mar 31, 2022 | 892,600.63 |
| Dec 31, 2021 | 138,337.10 |
| Mar 31, 2021 | 222,707.61 |